Breast cancer is commonly classified based on the expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), each of which drives cancer proliferation via the activation of precise downstream signaling cascades (Eliyatkın et al, 2015). This evidence concerns the gene ESR1 and cancer.